Free provider profile

MARK FESEN, MD

NPI 1639149545
Individual
Internal Medicine, Medical Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MARK FESEN?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MARK FESEN prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Imbruvica
  • Brukinsa
  • Revlimid
  • Xarelto
  • Lenalidomide

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

620-792-5511

Fax

620-792-5977

Practice address

204 CLEVELAND ST, GREAT BEND, KS, 67530

Registry updated
2024-10-10
NPI issued
2006-01-24
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

204 CLEVELAND ST, GREAT BEND, KS, 67530

620-792-5511

4 practice locations listed

Enumerated 2006-01-24

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — 4 practice locations listed — multi-site footprint.
  • — Record updated within the last three years.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,536

Medicare patients

199

Part D drug cost

$2,801,938

Brand-name share

Not published

of this prescriber's Part D claims

DrugClaimsMedicare cost
Imbruvica (Ibrutinib)43$669,094
Brukinsa (Zanubrutinib)30$435,543
Revlimid (Lenalidomide)25$392,367
Lenalidomide (Lenalidomide)15$212,842
Verzenio (Abemaciclib)12$208,874
Jakafi (Ruxolitinib Phosphate)12$200,931
Xtandi (Enzalutamide)12$160,582
Xarelto (Rivaroxaban)25$22,268

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across KS — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.